For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...
Certain low-risk or mature devices may see reduced trial requirements, but the broader trend is toward augmenting—not ...
During the discussion, he explained what he wants patients to understand about participating in clinical trials for their gastrointestinal cancers. Additionally, he imparted key updates from this ...
Everyday Health on MSN
Everything you need to know about placebos in cancer clinical trials
Would a placebo make cancer worse? Will I know if I am given a placebo in a clinical trial? Get answers to your pressing ...
Charlie Paterson, partner at PA Consulting, outlines how limited FDA guidance on innovative designs, decentralized models, and digital endpoints is forcing clinical operations teams to recalibrate ...
Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results